Home
/ Acrivon
/ Competitors

Acrivon Competitors and Similar CompaniesClear all

Acrivon's competitors and similar companies include Iksuda Therapeutics, Numab and OncoTherapy Science.

	Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.	Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.	Numab Numab Therapeutics is an oncology-focused biopharmaceutical company.	OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
Founding Date	Founding Date 2018	Founding Date 2007	Founding Date 2011	Founding Date 2001
Type	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations Watertown, US HQ Lund, SE	Locations Newcastle upon Tyne, GB HQ Newton, US	Locations Wädenswil, CH HQ	Locations Kawasaki, JP HQ
Employees	Employees 415% increase	Employees 43	Employees 681% decrease	Employees 54
Valuation ($)	Valuation ($) 256.1 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 56.9 m
Financial
Net income	Net income ($77.9m) (FY, 2025)	Net income N/A	Net income N/A	Net income (¥910.6m) (FY, 2026)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 47m (almost 5 years ago)	Latest funding round $ 110m (about 5 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 47m	Total funding raised $ 132.3m	Total funding raised N/A